Nafees Malik
Corporate Officer/Principal en Juvenescence, Inc. .
Perfil
Nafees N.
Malik was the founder of Asklepian Consulting Ltd.
founded in 2013, where he held the title of Managing Director.
Currently, he is the Head-Cell & Gene Therapy at Juvenescence, Inc. since 2018.
He was the Chief Operating Officer at AgeX Therapeutics, Inc. from 2018 to 2023.
Dr. Malik holds a doctorate degree from The University of Liverpool and a graduate degree from the University of Cambridge.
Cargos activos de Nafees Malik
| Empresas | Cargo | Inicio |
|---|---|---|
| Juvenescence, Inc. | Corporate Officer/Principal | 01/10/2018 |
Antiguos cargos conocidos de Nafees Malik.
| Empresas | Cargo | Fin |
|---|---|---|
| AGEX THERAPEUTICS, INC. | Chief Operating Officer | 27/12/2023 |
| Asklepian Consulting Ltd. | Chief Executive Officer | - |
Formación de Nafees Malik.
| The University of Liverpool | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
| Juvenescence, Inc. | Miscellaneous |
| Asklepian Consulting Ltd. |
- Bolsa de valores
- Insiders
- Nafees Malik
